Report Detail
Global Intelligent Cancer Care (ICC) Market Growth (Status and Outlook) 2023-2029
- RnM4532972 |
- 30 May, 2023 |
- Global |
- 122 Pages |
- LPI(LP Information) |
- Medical Industry
The global Intelligent Cancer Care (ICC) market size is projected to grow from US$ 871.6 million in 2022 to US$ 5247.4 million in 2029; it is expected to grow at a CAGR of 29.2% from 2023 to 2029.
United States market for Intelligent Cancer Care (ICC) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Intelligent Cancer Care (ICC) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Intelligent Cancer Care (ICC) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Intelligent Cancer Care (ICC) players cover Varian (Siemens), CityCancerChallenge, Canon, VieCure, Sophia Genetics, Freenome, Pfizer, IBM and Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Intelligent Cancer Care (ICC) is kind of information-driven network of next generation oncology solutions that bring people, data, and technology together to manage a more intelligent approach to cancer care.
LPI (LP Information)' newest research report, the “Intelligent Cancer Care (ICC) Industry Forecast” looks at past sales and reviews total world Intelligent Cancer Care (ICC) sales in 2022, providing a comprehensive analysis by region and market sector of projected Intelligent Cancer Care (ICC) sales for 2023 through 2029. With Intelligent Cancer Care (ICC) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intelligent Cancer Care (ICC) industry.
This Insight Report provides a comprehensive analysis of the global Intelligent Cancer Care (ICC) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intelligent Cancer Care (ICC) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intelligent Cancer Care (ICC) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intelligent Cancer Care (ICC) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intelligent Cancer Care (ICC).
This report presents a comprehensive overview, market shares, and growth opportunities of Intelligent Cancer Care (ICC) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Cancer Prevention and Screening
AI-Assisted Diagnosis
Prediction of Treatment Outcome
Intelligent Radiation Oncology
Tele-Oncology
Segmentation by application
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Varian (Siemens)
CityCancerChallenge
Canon
VieCure
Sophia Genetics
Freenome
Pfizer
IBM
Sanofi
GSK
Roche
Exscientia
BenevolentAI
Bayer
Philips
GE Healthcare
Azra AI
Path AI
NVIDIA
ConcertAI
Digital Diagnostics
Median Technologies
BioNTech SE
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Intelligent Cancer Care (ICC) Market Size 2018-2029
- 2.1.2 Intelligent Cancer Care (ICC) Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Intelligent Cancer Care (ICC) Segment by Type
- 2.2.1 Cancer Prevention and Screening
- 2.2.2 AI-Assisted Diagnosis
- 2.2.3 Prediction of Treatment Outcome
- 2.2.4 Intelligent Radiation Oncology
- 2.2.5 Tele-Oncology
- 2.3 Intelligent Cancer Care (ICC) Market Size by Type
- 2.3.1 Intelligent Cancer Care (ICC) Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Intelligent Cancer Care (ICC) Market Size Market Share by Type (2018-2023)
- 2.4 Intelligent Cancer Care (ICC) Segment by Application
- 2.4.1 Breast Cancer
- 2.4.2 Lung Cancer
- 2.4.3 Prostate Cancer
- 2.4.4 Colorectal Cancer
- 2.4.5 Brain Tumor
- 2.4.6 Others
- 2.5 Intelligent Cancer Care (ICC) Market Size by Application
- 2.5.1 Intelligent Cancer Care (ICC) Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Intelligent Cancer Care (ICC) Market Size Market Share by Application (2018-2023)
3 Intelligent Cancer Care (ICC) Market Size by Player
- 3.1 Intelligent Cancer Care (ICC) Market Size Market Share by Players
- 3.1.1 Global Intelligent Cancer Care (ICC) Revenue by Players (2018-2023)
- 3.1.2 Global Intelligent Cancer Care (ICC) Revenue Market Share by Players (2018-2023)
- 3.2 Global Intelligent Cancer Care (ICC) Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Intelligent Cancer Care (ICC) by Regions
- 4.1 Intelligent Cancer Care (ICC) Market Size by Regions (2018-2023)
- 4.2 Americas Intelligent Cancer Care (ICC) Market Size Growth (2018-2023)
- 4.3 APAC Intelligent Cancer Care (ICC) Market Size Growth (2018-2023)
- 4.4 Europe Intelligent Cancer Care (ICC) Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Intelligent Cancer Care (ICC) Market Size Growth (2018-2023)
5 Americas
- 5.1 Americas Intelligent Cancer Care (ICC) Market Size by Country (2018-2023)
- 5.2 Americas Intelligent Cancer Care (ICC) Market Size by Type (2018-2023)
- 5.3 Americas Intelligent Cancer Care (ICC) Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Intelligent Cancer Care (ICC) Market Size by Region (2018-2023)
- 6.2 APAC Intelligent Cancer Care (ICC) Market Size by Type (2018-2023)
- 6.3 APAC Intelligent Cancer Care (ICC) Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Intelligent Cancer Care (ICC) by Country (2018-2023)
- 7.2 Europe Intelligent Cancer Care (ICC) Market Size by Type (2018-2023)
- 7.3 Europe Intelligent Cancer Care (ICC) Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Intelligent Cancer Care (ICC) by Region (2018-2023)
- 8.2 Middle East & Africa Intelligent Cancer Care (ICC) Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Intelligent Cancer Care (ICC) Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Intelligent Cancer Care (ICC) Market Forecast
- 10.1 Global Intelligent Cancer Care (ICC) Forecast by Regions (2024-2029)
- 10.1.1 Global Intelligent Cancer Care (ICC) Forecast by Regions (2024-2029)
- 10.1.2 Americas Intelligent Cancer Care (ICC) Forecast
- 10.1.3 APAC Intelligent Cancer Care (ICC) Forecast
- 10.1.4 Europe Intelligent Cancer Care (ICC) Forecast
- 10.1.5 Middle East & Africa Intelligent Cancer Care (ICC) Forecast
- 10.2 Americas Intelligent Cancer Care (ICC) Forecast by Country (2024-2029)
- 10.2.1 United States Intelligent Cancer Care (ICC) Market Forecast
- 10.2.2 Canada Intelligent Cancer Care (ICC) Market Forecast
- 10.2.3 Mexico Intelligent Cancer Care (ICC) Market Forecast
- 10.2.4 Brazil Intelligent Cancer Care (ICC) Market Forecast
- 10.3 APAC Intelligent Cancer Care (ICC) Forecast by Region (2024-2029)
- 10.3.1 China Intelligent Cancer Care (ICC) Market Forecast
- 10.3.2 Japan Intelligent Cancer Care (ICC) Market Forecast
- 10.3.3 Korea Intelligent Cancer Care (ICC) Market Forecast
- 10.3.4 Southeast Asia Intelligent Cancer Care (ICC) Market Forecast
- 10.3.5 India Intelligent Cancer Care (ICC) Market Forecast
- 10.3.6 Australia Intelligent Cancer Care (ICC) Market Forecast
- 10.4 Europe Intelligent Cancer Care (ICC) Forecast by Country (2024-2029)
- 10.4.1 Germany Intelligent Cancer Care (ICC) Market Forecast
- 10.4.2 France Intelligent Cancer Care (ICC) Market Forecast
- 10.4.3 UK Intelligent Cancer Care (ICC) Market Forecast
- 10.4.4 Italy Intelligent Cancer Care (ICC) Market Forecast
- 10.4.5 Russia Intelligent Cancer Care (ICC) Market Forecast
- 10.5 Middle East & Africa Intelligent Cancer Care (ICC) Forecast by Region (2024-2029)
- 10.5.1 Egypt Intelligent Cancer Care (ICC) Market Forecast
- 10.5.2 South Africa Intelligent Cancer Care (ICC) Market Forecast
- 10.5.3 Israel Intelligent Cancer Care (ICC) Market Forecast
- 10.5.4 Turkey Intelligent Cancer Care (ICC) Market Forecast
- 10.5.5 GCC Countries Intelligent Cancer Care (ICC) Market Forecast
- 10.6 Global Intelligent Cancer Care (ICC) Forecast by Type (2024-2029)
- 10.7 Global Intelligent Cancer Care (ICC) Forecast by Application (2024-2029)
11 Key Players Analysis
- 11.1 Varian (Siemens)
- 11.1.1 Varian (Siemens) Company Information
- 11.1.2 Varian (Siemens) Intelligent Cancer Care (ICC) Product Offered
- 11.1.3 Varian (Siemens) Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 Varian (Siemens) Main Business Overview
- 11.1.5 Varian (Siemens) Latest Developments
- 11.2 CityCancerChallenge
- 11.2.1 CityCancerChallenge Company Information
- 11.2.2 CityCancerChallenge Intelligent Cancer Care (ICC) Product Offered
- 11.2.3 CityCancerChallenge Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 CityCancerChallenge Main Business Overview
- 11.2.5 CityCancerChallenge Latest Developments
- 11.3 Canon
- 11.3.1 Canon Company Information
- 11.3.2 Canon Intelligent Cancer Care (ICC) Product Offered
- 11.3.3 Canon Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Canon Main Business Overview
- 11.3.5 Canon Latest Developments
- 11.4 VieCure
- 11.4.1 VieCure Company Information
- 11.4.2 VieCure Intelligent Cancer Care (ICC) Product Offered
- 11.4.3 VieCure Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 VieCure Main Business Overview
- 11.4.5 VieCure Latest Developments
- 11.5 Sophia Genetics
- 11.5.1 Sophia Genetics Company Information
- 11.5.2 Sophia Genetics Intelligent Cancer Care (ICC) Product Offered
- 11.5.3 Sophia Genetics Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 Sophia Genetics Main Business Overview
- 11.5.5 Sophia Genetics Latest Developments
- 11.6 Freenome
- 11.6.1 Freenome Company Information
- 11.6.2 Freenome Intelligent Cancer Care (ICC) Product Offered
- 11.6.3 Freenome Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Freenome Main Business Overview
- 11.6.5 Freenome Latest Developments
- 11.7 Pfizer
- 11.7.1 Pfizer Company Information
- 11.7.2 Pfizer Intelligent Cancer Care (ICC) Product Offered
- 11.7.3 Pfizer Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 Pfizer Main Business Overview
- 11.7.5 Pfizer Latest Developments
- 11.8 IBM
- 11.8.1 IBM Company Information
- 11.8.2 IBM Intelligent Cancer Care (ICC) Product Offered
- 11.8.3 IBM Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 IBM Main Business Overview
- 11.8.5 IBM Latest Developments
- 11.9 Sanofi
- 11.9.1 Sanofi Company Information
- 11.9.2 Sanofi Intelligent Cancer Care (ICC) Product Offered
- 11.9.3 Sanofi Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 Sanofi Main Business Overview
- 11.9.5 Sanofi Latest Developments
- 11.10 GSK
- 11.10.1 GSK Company Information
- 11.10.2 GSK Intelligent Cancer Care (ICC) Product Offered
- 11.10.3 GSK Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 GSK Main Business Overview
- 11.10.5 GSK Latest Developments
- 11.11 Roche
- 11.11.1 Roche Company Information
- 11.11.2 Roche Intelligent Cancer Care (ICC) Product Offered
- 11.11.3 Roche Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 Roche Main Business Overview
- 11.11.5 Roche Latest Developments
- 11.12 Exscientia
- 11.12.1 Exscientia Company Information
- 11.12.2 Exscientia Intelligent Cancer Care (ICC) Product Offered
- 11.12.3 Exscientia Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 Exscientia Main Business Overview
- 11.12.5 Exscientia Latest Developments
- 11.13 BenevolentAI
- 11.13.1 BenevolentAI Company Information
- 11.13.2 BenevolentAI Intelligent Cancer Care (ICC) Product Offered
- 11.13.3 BenevolentAI Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.13.4 BenevolentAI Main Business Overview
- 11.13.5 BenevolentAI Latest Developments
- 11.14 Bayer
- 11.14.1 Bayer Company Information
- 11.14.2 Bayer Intelligent Cancer Care (ICC) Product Offered
- 11.14.3 Bayer Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.14.4 Bayer Main Business Overview
- 11.14.5 Bayer Latest Developments
- 11.15 Philips
- 11.15.1 Philips Company Information
- 11.15.2 Philips Intelligent Cancer Care (ICC) Product Offered
- 11.15.3 Philips Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.15.4 Philips Main Business Overview
- 11.15.5 Philips Latest Developments
- 11.16 GE Healthcare
- 11.16.1 GE Healthcare Company Information
- 11.16.2 GE Healthcare Intelligent Cancer Care (ICC) Product Offered
- 11.16.3 GE Healthcare Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.16.4 GE Healthcare Main Business Overview
- 11.16.5 GE Healthcare Latest Developments
- 11.17 Azra AI
- 11.17.1 Azra AI Company Information
- 11.17.2 Azra AI Intelligent Cancer Care (ICC) Product Offered
- 11.17.3 Azra AI Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.17.4 Azra AI Main Business Overview
- 11.17.5 Azra AI Latest Developments
- 11.18 Path AI
- 11.18.1 Path AI Company Information
- 11.18.2 Path AI Intelligent Cancer Care (ICC) Product Offered
- 11.18.3 Path AI Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.18.4 Path AI Main Business Overview
- 11.18.5 Path AI Latest Developments
- 11.19 NVIDIA
- 11.19.1 NVIDIA Company Information
- 11.19.2 NVIDIA Intelligent Cancer Care (ICC) Product Offered
- 11.19.3 NVIDIA Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.19.4 NVIDIA Main Business Overview
- 11.19.5 NVIDIA Latest Developments
- 11.20 ConcertAI
- 11.20.1 ConcertAI Company Information
- 11.20.2 ConcertAI Intelligent Cancer Care (ICC) Product Offered
- 11.20.3 ConcertAI Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.20.4 ConcertAI Main Business Overview
- 11.20.5 ConcertAI Latest Developments
- 11.21 Digital Diagnostics
- 11.21.1 Digital Diagnostics Company Information
- 11.21.2 Digital Diagnostics Intelligent Cancer Care (ICC) Product Offered
- 11.21.3 Digital Diagnostics Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.21.4 Digital Diagnostics Main Business Overview
- 11.21.5 Digital Diagnostics Latest Developments
- 11.22 Median Technologies
- 11.22.1 Median Technologies Company Information
- 11.22.2 Median Technologies Intelligent Cancer Care (ICC) Product Offered
- 11.22.3 Median Technologies Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.22.4 Median Technologies Main Business Overview
- 11.22.5 Median Technologies Latest Developments
- 11.23 BioNTech SE
- 11.23.1 BioNTech SE Company Information
- 11.23.2 BioNTech SE Intelligent Cancer Care (ICC) Product Offered
- 11.23.3 BioNTech SE Intelligent Cancer Care (ICC) Revenue, Gross Margin and Market Share (2018-2023)
- 11.23.4 BioNTech SE Main Business Overview
- 11.23.5 BioNTech SE Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Intelligent Cancer Care (ICC). Industry analysis & Market Report on Intelligent Cancer Care (ICC) is a syndicated market report, published as Global Intelligent Cancer Care (ICC) Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Intelligent Cancer Care (ICC) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
